期刊文献+

血清降钙素原水平在肝移植术后并发肺部感染患者中的诊断价值 被引量:8

The detection of procalcitonin in pneumonia patients after liver transplantation
下载PDF
导出
摘要 目的探讨降钙素原(PCT)的检测对肝移植术后细菌性中老年肺炎患者临床诊断价值。方法回顾性分析该院22例行肝脏移植术后并发肺部感染的中老年患者,将其分为细菌性肺炎感染组和非细菌性肺炎感染组。提取两组患者发热初期及48 h血清,检测PCT和C反应蛋白(CRP)浓度,采用受试者工作特征曲线(ROC)评价并比较两组敏感性和特异性差异。结果 PCT在肝移植术后并发细菌性肺炎患者与非细菌性肺炎患者中的水平有统计学差异(P<0.05),CRP水平无统计学差异(P>0.05)。ROC曲线表明细菌性肺炎组和非细菌性肺炎组发热初期PCT和CRP敏感性及特异性均较差;但患者病情发展48 h后,PCT比CRP表现出更好的敏感性和特异性(100%vs 86%,87%vs 71%,P<0.05)。结论 PCT比CRP更能灵敏地检测到肝移植术后患者细菌性肺炎的发展及预后。 Objective To investigate the clinical diagnostic value of procalcitonin (PCT) after liver transplantation in older patients with bacterial pneumonia .Methods A retrospective analysis was performed on 22 old patients who got pneumonia infection after liver trans-plantation.The patients were divided into bacterial pneumonia infection and non-bacterial pneumonia groups .Extracted serums was used to detect PCT and C-reactive protein(CRP) at fever early and after 48 hours,the results were compared by ROC.Res ulst The level of PCT had statistically significant difference between the two groups ( P〈0.05 ) .The level of CRP had no significant difference ( P〉0.05 ) .ROC showed that sensitivity and specificity of PCT and CRP were poor ,but PCT showed better sensitivity and specificity (100%vs 86%,87%vs 71%, P〈0.05 ).Con clusions PCT is more sensitive to detect the development of patients after liver transplantation with bacterial pneumo -nia,and provide better and rapid clinical diagnosis .
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第22期6245-6247,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金项目(81171992)
关键词 肝移植 肺炎 降钙素原 细菌感染 Liver transplant Pneumonia Procalcitonin Bacterial infection
  • 相关文献

参考文献12

  • 1Levesque E,Hoti E,Azoulay D,et al.Pulmonary complications after elective liver transplantation-incidence,risk factors,and outcome[J].Transplantation,2012;15;94(5):532.
  • 2Meisner M,Tschaikowsky K,Palmaers T,et al.Comparison of procalcitonin(PCT)and C-reactive protein(CRP)plasma concentrations at different SOFA scores during the course of sepsis.
  • 3Schuetz P,Albrich WC,Mueller B.Procalcitonin for diagnosis of infection and guide to antibiotic decisions past present and future[J].BMC,Med,2011;9(1):107.
  • 4胡可,刘文恩,梁湘辉.降钙素原在细菌感染中临床应用的研究[J].中华医院感染学杂志,2011,21(1):30-33. 被引量:275
  • 5Shorr AF,Susla GM,O'Grady NP.Pulmonary infiltrates in the non-HIVinfected immunocompromised patient:etiologies,diagnostic strategies,and outcomes[J].Chest,2004;125(1):260-71.
  • 6Linhares MM,Gonzalez AM,Trivino T,et al.Simultaneous pancreas-kidney transplantation:infectious complications and microbiological aspects[J].Transplant Proc,2004;36(4):980-1.
  • 7Grammatikopoulos T,Dhawan A,Bansal S,et al.Baseline evaluation of serum markers of inflammation and their utility in clinical practice in paediatric liver transplant recipient.
  • 8Van den Broek MA,Olde Damink SW,Winkens B,et al.Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care uni[tJ].L.
  • 9王大明,朱滨,丁良才,张劲松.降钙素原在肾移植术后患者肺部感染诊断中的应用[J].中华急诊医学杂志,2011,20(5):524-527. 被引量:29
  • 10Don M,Valent F,Korppi M,et al.Efficacy of serum procalcitonin in evaluating severity of community acquired pneumonia in childhood[J].Scand Infect Dis,2007;39(2):129-37.

二级参考文献22

共引文献301

同被引文献73

  • 1蔡川奇,林志鸿,蔺佩鸿,江勇,郭平清.血清白蛋白和前白蛋白对老年肺炎病情的预测价值[J].中国老年学杂志,2014,34(1):103-105. 被引量:30
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3052
  • 3Schuetz P, Albrich WC, Mueller B. Procaleitonin for diagnosis of infection and guide to antibiotic decisions [J]. BMC Med, 2011, 9: 107. doi: 10,1186/1471-7015-9-107.
  • 4Ruiz-Rodriguez J, Rello J. Predicting treatment failure in severe sepsis and septic shock [J]. Crit Care, 2013, 17 (5): 180. doi: 10,1186/cc12877.
  • 5Schuetz P, Maurer P, Punjabi V, et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients [J]. Crit Care, 2013, 17 (3): R115.
  • 6JekarlDW, Lee SY, Lee J, et al. Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis[J]. Diagn Microbiol Infect Dis, 2013, 75 (4): 342- 347.
  • 7KrUger St Ewig S, Marre R, et al. Procalcitonin predicts patients at low' risk :of death from community-acquired pneumonia across all CRB-65 classes [J]. Eur Respir J, 2008, 31 (2): 349-355.
  • 8Espaa PP, Capelastegui A, Bilbao A, et al. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia [ J]. Eur J Clin Microbiol Infect Dis, 2012, 31 (12): 3397-3405.
  • 9Nyamande K, Lalloo UG. Serum procaleitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP [J]. Int J Tuberc Lung Dis, 2006, 10 (5) : 510-515.
  • 10Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community- acquired pneumonia [J]. Ann Emerg Med, 2008, 52 (1): 48-58.

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部